Which medication, if taken with an ACE inhibitor, increases the risk of hyperkalemia?

Study for the NCLEX Pharmacology Cardiovascular Drugs Test. Explore multiple choice questions with detailed explanations and hints. Prepare confidently for your NCLEX exam!

Multiple Choice

Which medication, if taken with an ACE inhibitor, increases the risk of hyperkalemia?

Explanation:
When a drug that affects aldosterone is added to an ACE inhibitor, the risk of high potassium rises. Spironolactone is a potassium-sparing diuretic that blocks aldosterone’s action in the distal nephron, so less potassium is excreted. An ACE inhibitor already lowers aldosterone production; combining it with spironolactone therefore markedly reduces potassium loss and can elevate serum potassium, leading to hyperkalemia. Clinically, this means monitoring potassium and kidney function, watching for symptoms like muscle weakness or irregular heartbeats, and avoiding high-potassium foods or salt substitutes. Other options don’t raise this risk with an ACE inhibitor: a stool-softening agent has no electrolyte effect; a loop diuretic like furosemide increases potassium excretion; and morphine has no direct impact on potassium homeostasis.

When a drug that affects aldosterone is added to an ACE inhibitor, the risk of high potassium rises. Spironolactone is a potassium-sparing diuretic that blocks aldosterone’s action in the distal nephron, so less potassium is excreted. An ACE inhibitor already lowers aldosterone production; combining it with spironolactone therefore markedly reduces potassium loss and can elevate serum potassium, leading to hyperkalemia. Clinically, this means monitoring potassium and kidney function, watching for symptoms like muscle weakness or irregular heartbeats, and avoiding high-potassium foods or salt substitutes.

Other options don’t raise this risk with an ACE inhibitor: a stool-softening agent has no electrolyte effect; a loop diuretic like furosemide increases potassium excretion; and morphine has no direct impact on potassium homeostasis.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy